A stitch in time: 3-monthly long-acting injectable paliperidone palmitate in schizophrenia

被引：6
|
作者：
Taylor, Mark [1 ]
Huang, Hannah Chu-Han [2 ]
机构：
[1] Univ Queensland, Inala Mental Hlth, 64 Wirraway Pde, Brisbane, Qld 4077, Australia
[2] South London & Maudsley Trust, London, England
来源：
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY | 2017年 / 7卷 / 10期
关键词：
INJECTIONS;
D O I：
10.1177/2045125317721874
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：231 / 233
页数：3
相关论文
共 50 条
  • [1] Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
    Brasso, Claudio
    Bellino, Silvio
    Bozzatello, Paola
    Montemagni, Cristiana
    Rocca, Paola
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2767 - 2779
  • [2] Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia
    Oh, Jihoon
    Oh, Jihye
    Kim, Dong Wook
    Youn, HyunChul
    Kim, Sae-Hoon
    Kim, Soo In
    Chung, In Won
    Wang, Kuan Shu
    Kim, Minah
    Paik, Jong -Woo
    Koh, Min Jung
    Lee, Yoosun
    Choi, Seok Young
    Kim, Jung-Jin
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2023, 21 (01) : 126 - 134
  • [3] Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation
    Corbeil, Olivier
    Essiambre, Anne-Marie
    Bechard, Laurent
    Roy, Audrey-Anne
    Huot-Lavoie, Maxime
    Brodeur, Sebastien
    Chandrasena, Ranjith
    Theriault, Chantale
    Crocker, Candice
    Melun, Jean-Pierre
    Tibbo, Phil
    Demers, Marie-France
    Roy, Marc-Andre
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2022, 12
  • [4] A case report of pregnancy and paliperidone palmitate 3-monthly long-acting injection
    de Azevedo Avelar, Rita
    Luengo Corbal, Antonio
    Heitor, Maria Joao
    CLINICAL CASE REPORTS, 2020, 8 (12): : 2592 - 2594
  • [5] Long-acting injectable paliperidone palmitate in a haemodialysis patient with schizophrenia
    Lin, Jia-Hong
    Tsai, Tsung-Huang
    Lee, Chia-Shun
    Yang, Ya-Hui
    Chen, Kuang-Peng
    Tung, Chun-Liong
    Tsai, Jui-Hsiu
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (08): : 829 - 830
  • [6] Use of 3-monthly long-acting injectable paliperidone on acute inpatient psychiatric unit
    Hernandez Huerta, D.
    Soto-Ruano, A.
    Montes-Rodriguez, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S392 - S393
  • [7] Cost-effectiveness analysis of monthly, 3-monthly, and 6-monthly long-acting injectable and oral paliperidone in adults with schizophrenia
    Wang, Grace Hsin-Min
    Svensson, Mikael
    Shao, Hui
    Vouri, Scott Martin
    Park, Haesuk
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (08): : 884 - 895
  • [8] Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia : A Critical Appraisal
    Garcia-Carmona, Juan Antonio
    Pappa, Sofia
    DRUG HEALTHCARE AND PATIENT SAFETY, 2023, 15 : 113 - 123
  • [9] Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs
    Di Lorenzo, Rosaria
    Iorio, Anita
    Pinelli, Margherita
    Magarini, Federica
    Marchi, Mattia
    Sacchetti, Andrea
    Calogero, Chiara
    Galeazzi, Gian Maria
    Ferri, Paola
    Rovesti, Sergio
    Minarini, Alessandro
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 829 - 846
  • [10] A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia
    Fleischhacker, W. Wolfgang
    Gopal, Srihari
    Lane, Rosanne
    Gassmann-Mayer, Cristiana
    Lim, Pilar
    Hough, David
    Remmerie, Bart
    Eerdekens, Marielle
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (01): : 107 - 118
12345